Karunadu Oncology Haematology Associates Private Limited - Company Profile

It is a healthcare private limited company based in Hubballi, Karnataka, India, established in 2018.
2018 Hubballi, Karnataka, India Active
Last Updated:
Access Report
About Karunadu Oncology Haematology Associates Private Limited

Karunadu Oncology Haematology Associates Private Limited, a active private limited company, was established on 18 December 2018 in Hubballi, Karnataka, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85320KA2018PTC119596. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.30 Cr.

Its leadership includes Jagadish Tubachi Basavaraj (Director), Pran Prasa Nna Hanumanthu (Director), Lakshmi (Director). Past directors included Pran Prasa Nna Hanumanthu. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Madura Chetana Colony 123 Keshwapur, Hubballi, Karnataka, 580023.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85320KA2018PTC119596

  • Registration Number

    119596

  • Incorporation Date

    18 December 2018

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.30 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.30 Cr
  • Company Age 7 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 10.00 Cr
Company report

Karunadu Oncology Haematology Associates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Karunadu Oncology Haematology Associates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Karunadu Oncology Haematology Associates Private Limited?
Current Directors
Name Designation Appointment Date Status
Jagadish Tubachi Basavaraj Director 18 Dec 2018 Current
Pran Prasa Nna Hanumanthu Director 01 Aug 2022 Current
Lakshmi Director 26 Jun 2021 Current
Rajeev Director 26 Jun 2021 Current
Snehalreddy Director 18 Dec 2018 Current
Santosh Chandru Kulgod Director 20 Jun 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Karunadu Oncology Haematology Associates.

Karunadu Oncology Haematology Associates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Karunadu Oncology Haematology Associates revenue growth over time
Karunadu Oncology Haematology Associates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Karunadu Oncology Haematology Associates?

In 2023, Karunadu Oncology Haematology Associates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹100,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 10.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Sep 2021 State Bank Of India ₹10.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Karunadu Oncology Haematology Associates?

Unlock and access historical data on people associated with Karunadu Oncology Haematology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Karunadu Oncology Haematology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karunadu Oncology Haematology Associates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Karunadu Oncology Haematology Associates
Recent Activity within the Organization
  • Director Appointment

    Gajula Mehar Kumar was appointed as a Director was appointed as a Director on 24 Nov 2025 & has been associated with this company since 3 months 7 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Karunadu Oncology Haematology Associates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Karunadu Oncology Haematology Associates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Pran Prasa Nna Hanumanthu was appointed as a Director was appointed as a Director on 01 Aug 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 10.00 Cr with Charge ID 100482240 was registered on 27 Sep 2021. was documented.

  • Director Appointment

    Lakshmi was appointed as a Director was appointed as a Director on 26 Jun 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Karunadu Oncology Haematology Associates Private Limited?

The CIN of Karunadu Oncology Haematology Associates Private Limited is U85320KA2018PTC119596.

Where is Karunadu Oncology Haematology Associates Private Limited headquartered?

Karunadu Oncology Haematology Associates Private Limited is headquartered at Madura Chetana Colony 123 Keshwapur, Hubballi, Karnataka, 580023.

When was Karunadu Oncology Haematology Associates Private Limited incorporated?

Karunadu Oncology Haematology Associates Private Limited was incorporated on 18 December 2018.

Who are the current directors of Karunadu Oncology Haematology Associates Private Limited?

The current directors of Karunadu Oncology Haematology Associates Private Limited are

What is the primary industry of Karunadu Oncology Haematology Associates Private Limited?

The primary industry of Karunadu Oncology Haematology Associates Private Limited is Hospital And Medical Care.

Is Karunadu Oncology Haematology Associates Private Limited a listed company?

Karunadu Oncology Haematology Associates Private Limited is unlisted.

What is the capital structure of Karunadu Oncology Haematology Associates Private Limited?

The authorized capital of Karunadu Oncology Haematology Associates Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.30 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available